Kellner Capital, LLC Cerevel Therapeutics Holdings, Inc. Transaction History
Kellner Capital, LLC
- $55.5 Million
- Q4 2023
A detailed history of Kellner Capital, LLC transactions in Cerevel Therapeutics Holdings, Inc. stock. As of the latest transaction made, Kellner Capital, LLC holds 20,300 shares of CERE stock, worth $0. This represents 1.55% of its overall portfolio holdings.
Number of Shares
20,300Holding current value
$0% of portfolio
1.55%Shares
1 transactions
Others Institutions Holding CERE
# of Institutions
9Shares Held
5.01MCall Options Held
3.3KPut Options Held
0-
Black Rock Inc. New York, NY3.56MShares$00.0% of portfolio
-
Segantii Capital Management LTD1.14MShares$05.99% of portfolio
-
Tekla Capital Management LLC176KShares$00.22% of portfolio
-
Credit Suisse Ag Zurich, V8112KShares$00.0% of portfolio
-
Ifp Advisors, Inc764Shares$00.0% of portfolio
About Cerevel Therapeutics Holdings, Inc.
- Ticker CERE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 155,752,000
- Description
- Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...